Ligation Devices Market 2020 Global Market Analysis, Demand, Key Players, Future Growth By 2023

 Market Highlights

Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,

Market research future will be publishing a Half cooked research report on “Global  ligature Devices Market” that contains the information from 2019 to 2024. Ligation Devices Market is expected to grow at a CAGR 6.7% during the forecast period of 2019 to 2024.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7794 

Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.

000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.

Regional Analysis

The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.

In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.

On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.

Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/ligation-devices-market-7794

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medication Management Market Perceive A Distinctive Growth at a CAGR 13.4% By 2023

 Medication Management Market Research Report: by systems (Computerized Physician Order Entry Systems, Administration Software, others), services (Point-Of-Care Verification Services, others), mode of delivery, end user – Global forecast till 2023

Market Insights

Market Research Future predicted that the global Medication management System market is set to reach the highest CAGR of 13.4% through the forecast period, 2018-2023.

Medication management focuses on improving medication use for the patient's condition. Interventions may include medication alignment, medication management, patient / family education about medications, and patient medication configuration simulations.

The growing geriatric population is one of the most important factors in the drug management market. Older people often have significant comorbidities that increase drug use and the risk of poor outcomes. According to a 2018 study published in Clinical Epidemiology, polypharmacy affects between 40% and 50% of older people in countries with high-income. Polypharmacy increases the risk of drug-related side effects in older people because more drugs are associated with a higher risk of harmful drug interactions. Several other factors, such as the emergence of funds in the healthcare sector and the need to reduce healthcare costs, are some of the drivers of the market.

However, the high costs of software implementation and service maintenance can hinder the market growth during the forecast period.

Market Segmentation

The global Medication management System market is segmented based on systems, services, delivery methods, and end-user.

The global system-based medication management market is divided into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems, and assurance systems. Administration software segment is further classified as Bar Code Drug Delivery Software (BCMA) and Electronic Drug Management Software (eMAR). The automatic distributor's segment is further classified as centralized automated distribution systems and decentralized automated distribution systems (ADS). A centralized automated dosing system includes robots / dosing systems and automated carousels. The decentralized automated dispensing system (ADS) comprises automated decentralized unit dose metering systems, pharmacy-based decentralized automated dispensing systems, and service-based decentralized automated dispensing systems.

The services market segment is subdivided into point-of-care verification services and drug side effects monitoring.

The global market, on the basis of delivery mode, is divided into on-premise solutions, web-based solutions, and cloud-based solutions.

The market is segmented into pharmacies, hospitals, healthcare facilities, research institutes, and others, based on end-user.

Regional Outlook

The United States has dominated the global drug management market. This growth can be ascribed to the rise in the elderly population and the presence of the main market players in the region.

Europe ranked second in 2017 due to the presence of developed economies such as the United Kingdom, Germany, France, and other countries in the region, which is an engine for market growth.

The Asia Pacific region is likely to see the fastest growth in 2017. Factors such as health technology sector growth, increasing market penetration in the region, and growing government support for foreign investment provide regional markets in the region. Asia Pacific.

In addition, the Middle East and Africa had the lowest share of the global drug management market due to the existence of low per capita income and poor economies, especially in the African region. The Middle East region is considered an important market for the Middle East and Africa region.

 

Major Players

The leading players that are supporting the functioning of the global medication management market include General Electric Company, Siemens Ltd, Medical Information Technology, QuadraMed Affinity Corporation, Allscripts Healthcare Solutions, Cerner Corporation, Mckesson Corporation, Omnicell, Inc., Carefusion Corporation, Epic Systems Corporation, and Optum Inc.

Recent Updates

• Omnicell, Inc., a leading  of medication management solutions for healthcare and pharmacy systems, has announced that Mercy, one of five US healthcare systems for Oklahoma, Arkansas, Missouri, and Kansas, will take over the management of medication in your service network through its Omnicell's automation and intelligence solutions. Omnicell works with major healthcare systems, such as Mercy, and the company launches its vision for independent pharmacies, a step-by-step plan for developing a fully automated zero-error drug management infrastructure. Based on automation, data intelligence, and specialized services, the autonomous pharmacy will allow pharmacists, nurses, physicians, and pharmacist staff to focus on patient and physician satisfaction.

 

Read More @ https://www.marketresearchfuture.com/reports/medication-management-market-7187 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Neurovascular Devices Market 2020-Trends, Analysis by @023

 Global Market for Neurovascular Devices to Exhibit an Above-Average Growth over the Next Six Years 

Neurovascular devices are increasingly being used in for treating and management of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm. As the global burden of neurovascular disorders continue to rise, the demand for their treatments gains further traction. Neurovascular disease are complex in nature and hence preference for minimally invasive procedures is higher. This, in turn, is driving the sales of neurovascular devices across the globe. Market Research Future (FRMR) is its latest report asserts that the global market for neurovascular devices will grow at a healthy rate over the next couple of years. 

Incessant product innovation, increased product marketing and favourable reimbursement policies are driving the global market for neurovascular devices. Other factors that are reflecting favourably on the market include expansion of the geriatric population, and advances in medical technology in the field of interventional neurology.  Moreover, neurovascular devices are also used in treating patients suffering for ischemic stroke or haemorrhagic. It has been observed that neurovascular device assisted interventional procedures are replacing the traditional neurosurgeries. Owing the low risk of damaging surrounding tissues and minimal surgical trauma, interventional procedure are more favoured as compared to neurosurgery. At the same time, chances of infection is significantly when neurovascular device based treatment. On the other hand, inadequate number of hilly skilled neurologist, particularly in developing countries expected to have a negative impact on the growth of the market. High cost of neurovascular devices continue to limit their user base despite their increased efficiency. 

Latest Industry Highlights:

• Perflow Medical, a renowned medical devices manufacturing company based in Israel, which is primarily engaged in developing novel solution for neurovascular interventions. Has recently announced that the company successfully approved a $12 Mn funding from its investors. Reportedly, the funding syndicate in included two new international investors with the existing stakeholders. 

• Junkosha a US-based company has recently introduced a unique peelable heat shrink. The technology will reportedly enable access to intricate parts of the vascular system with minimal risk of damage to the surroundings. 

Global Market for Neurovascular Devices – Segmental Analysis 

MRFR in its report has offer comprehensive segmental analysis of the market based on therapeutic application, end-user and product. By therapeutic application, the market is bifurcated into ischemic strokes and hemorrhagic stroke. Based on end user, the market is segment into ambulatory surgical units and hospitals & clinics. By product type, the market is segmented into stenting systems, neurothrombectomy devices, cerebral balloon angioplasty, aneurysm coiling & embolization devices and support device. 

Regional Overview 

The Americas is expected to hold the dominant position in the global Neurovascular Devices market for neurovascular devices. This is primarily attributed to the rising incidences of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm across North and South America. In addition, presence of major players and rising healthcare spending among Americans is propelling the market in the region. Improved reimbursement scenario and rapid adoption of neurovascular devices in neurological centers across the region is also proving an impetus to the market. Asia Pacific and Europe are two other regions anticipated to present significant growth opportunities for market during the forecast period. 

Global Market for Neurovascular Devices – Competitive Analysis

Leading companies operating in the global market for neurovascular devices include Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Penumbra, Inc., Evasc, Neuravi, Sensome, Delaware Corporation, Gynesonics, Stryker, Johnson & Johnson Services, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Rapid Medical, W. L. Gore & Associates, Inc., Blockade Medical, LLC., OxfordEndovascular, and Secant Group, LLC. A majority of these market participants are actively focusing on expanding market presence by engaging in merger & acquisition and reaching offshore distribution agreements with third party vendors. 

Read More @ https://www.marketresearchfuture.com/reports/neurovascular-devices-market-5544 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Retinal Implants Market 2018 – Leading Manufactures, Regions, Drivers, Analysis and Forecasts Till 2025

 Retinal implants have proven its mettle as a breakthrough therapy in the treatment of visual impairment. The global retinal implants market is perceived to be growing at a recurring rate and is expected to reach high revenue figures in the coming years, as per the analysis of Market Research Future (MRFR).  The global retinal implant market has been flourishing on account of the widespread prevalence of eye disorders across the globe. Growing cases of retinal disorders have induced high demand for retinal implants since they aid in the restoration of vision. Retinal implants have demonstrated significance for application in eye disorders which were once far-off impossible to achieve. The fact that these devices can be implanted with minimally invasive procedures has added to its popularity and driven the market. The rise in geriatric population is a crucial factor driving the growth of the retinal implant market. Owing to various health insufficiencies, the aging population is more susceptible to acquiring visual impairment and require retinal implant.

Request Free Sample @https://www.marketresearchfuture.com/sample_request/6580

Substantial investment in R&D activities by various medical device manufacturers and governments have led to the development of advanced retinal implants which can be successfully implanted in patients. Extensive clinical trial activities have also contributed to the growth of the market. Few retinal implants have already cleared clinical trials, and many more are underway which is expected to spur the market in the future. In addition, the rise in a number of FDA approvals has been a plus for the growth of the global retinal implants market.

A large number of retinal implants are due for approval and patent from various regulatory authorities, the market stores opportunities for expansion. Also, expected expansion in reimbursement coverage for retinal implants is also expected to augment the market in the coming years. Other driving factors include the rise in the prevalence of degenerative diseases and raising awareness regarding the availability of the device which raises adoption. However, lack of skilled medical professionals with adequate knowledge of performing surgery and stringent and complex FDA approval process remains a significant hurdle for the growth of the global retinal implants market. High costs associated with retinal implants, the risk of biocompatibility and unknown long-term efficacy of the product are also expected to hinder adoption.

Segmentation

The global retinal implants market has been segmented into device type, disease indication, and end user. By device type, the market has been segmented into retina implant alpha AMS, Argus II, implantable miniature telescope, and others.  By disease indication, the market has been segmented into age-related macular degeneration (AMD) and retinitis pigmentosa. By end user, the market has been segmented into multi-specialty hospitals, ophthalmic clinics, and research institutes.

Access Report @ https://www.marketresearchfuture.com/reports/retinal-implants-market-6580

Regional Analysis

North America, Europe, Asia Pacific, and the Rest of the World are the key markets for retinal implants. North America accounts for a substantial share of the global market. Higher availability of the product, improving reimbursement scenario and higher affordability in the region supports the growth of the North America market for retinal implants. Presence of highly skilled surgeons to perform immensely complex surgical procedure also accelerates adoption in the region.

In Europe, the market is driven by an increase in R&D activities and the expansion of clinical trials.

Presence of developing countries such as India, China, and Japan, who outlay massive amounts on healthcare expenditure, coupled with growing disposable income and affordability supports the growth of the market in Asia Pacific.

Rest of the World market is expected to fare well in the coming years since various market players are foraying into the untapped regions to leverage the potential they offer for market expansion.

Competitive Landscape

Second Sight Medical Products, Inc.; Retina Implant AG,  VisionCare, Inc., Bionic Vision Australia (BVA), Bionic Eye Technologies, Inc., and Visus Technology, Inc. are the key players operating in the global retinal implants market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Spirometry market News, Trends, Demand and Forecast

 Overview:

The global Spirometry market is witnessing a significant rise in its revenues, mainly due to the rising occurrences of respiratory diseases such as asthma and COPD. Besides, the growing rate of diagnosis processes conducted for the detection of interstitial pulmonary fibrosis fosters the growth of the market. Moreover, the increasing exposure to risk factors and the ever-increasing population is driving a large share of the market.

According to Market Research Future (MRFR), the global Spirometry market is expected to garner a valuation of USD 1,106.76 MN by 2023, registering 10.03% CAGR over the assessment period (2018-2023). Factors such as the increasing healthcare expenditures and technological advances in respiratory care devices are estimated to support market growth over the forecast period.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6539 

Drivers & Restraints: 

Spirometry is a medical test to evaluate lung functions vital for detecting asthma, COPD, and other breathing disorders. Spirometry is also performed for therapeutic reasons for asthma, chronic obstructive pulmonary disease, and restrictive lung disease. Growing exposure to risk factors, including smoking and pollutants such as chemicals, fumes, and dust, is fostering the growth of the market, increasing the prevalence of respiratory diseases. 

On the other hand, factors such as the high cost of tests that require different spirometers and reimbursement limitations are inhibiting the growth of the market. Nevertheless, factors such as the growing government initiatives to spread the awareness and funding support to drive R&D required to improve diagnostics techniques and devices would support the growth of the market throughout the assessment period.  

Global Spirometry Market – Segments

The analysis is segmented into five main dynamics to widen the scope of understanding,

By Product : Table-top Spirometry, Hand-held Spirometry, and Desktop (PC) Spirometry, and others. 

By Technology : Flow Measurement Spirometry (Pneumotachograph System and Mass Flow Meter), Volume Measurement Spirometry, Peak Flow Meter (PFM), and others.

By Application : Diagnostic (Asthma, COPD, Interstitial Pulmonary Fibrosis, others), Treatment Monitoring, and others.

By End-user : Hospitals & Clinics, Research & Academic Institutes, Diagnostic Centers, Home Care, and others.

By Regions : Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World.

 

Global Spirometry Market – Regional Analysis

North America dominates the global Spirometry market with the growing prevalence of respiratory diseases such as asthma, COPD, interstitial pulmonary fibrosis, and others. Besides, the huge technological advancements and rising adoption of Spirometry devices for improved diagnosis processes drive the regional market growth. Also, factors such as the availability of state-of-the-art facilities & infrastructure and growing awareness are fostering the demand in the regional market.

Additionally, the presence of large payers, high healthcare expenditures, and expanding rebate on diagnostics is further promoting the growth of the regional market. The North American Spirometry market is estimated to create a valuation of USD 444.99 MN by 2023, registering 10.25% CAGR during the forecast period.

Europe stands second in the spirometry market, growing rapidly. Factors such as the presence of large medical device companies in Germany and increasing healthcare expenses substantiate the growth of the regional market. Moreover, the proliferating healthcare industry and developed infrastructure in the region are major factors that are driving the market growth further. The European spirometry market valuation is expected to climb up to USD 322.33 MN by 2023, posting 10.25% CAGR throughout the review period.

The Asia Pacific Spirometry market has been witnessing significant growth, demonstrating the tremendous potential for future growth. Low diagnostic costs and large unmet clinical needs for respiratory diseases in the region provide ample opportunities for market growth. The valuation of the APAC Spirometry market is estimated to reach USD 247.52 MN by 2023, registering 10.64% CAGR during 2018-2023.

 Read More !! https://www.marketresearchfuture.com/reports/spirometry-market-6539 

Global Spirometry Market – Competitive Landscape

Highly competitive, the Spirometry market appears to be fragmented due to the presence of several well-established players. There is a definite shift towards the hospital testing department, which dominates a large market share. As a result, players rely on their collaborations and partnerships with hospitals to increase market penetration of their products. Besides, these players employ numerous distributions channels and engage healthcare payers such as insurance companies to enhance their competitive share. 

Major Players:

Players leading the global Spirometry market include NDD Medical Technologies, Inc. (US), Carefusion Corporation (US), Nihon Kohden Corporation (Germany), Vitalograph (UK), MGC Diagnostics Corporation (US), Schiller AG (Switzerland), Hill-Rom Holdings, Inc. (US), COSMED Srl. (Italy), Midmark Corporation (US), Koninklijke Philips N.V. (Netherlands), and Smiths Medical Inc. (US), among others. 

Industry/ Innovation/ Related News:

December 04, 2019 ---- VivaLNK Connected Health Solutions (the US), a leading global provider of wearable medical solutions for continuous patient monitoring, announced scoring a CE mark for its multi-vital medical wearable sensor, SDK. VivaLNK mentioned that it had landed a Class IIa medical device CE Mark for its multi-vital medical wearable sensor & software development kit. The new technology allows researchers & clinicians to continuously stream a patient’s respiratory rate, ECG rhythm, heart rate, and RR interval & three-axis acceleration.

The company also mentioned that it has recently signed a deal with Current Health (the UK), a leading healthcare technology company for the distribution of VivaLNK that offers axillary temperature and spirometry measurements capabilities sighting on the European market. The company also claims that its sensors have been integrated into clinical trial monitoring and heart failure detection as well. 

Market Research Future 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various 

industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw 

Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting 

Services. 

MRFR team have supreme objective to provide the optimum quality market research and intelligence 

services to our clients. Our market research studies by products, services, technologies, applications, 

end users, and market players for global, regional, and country level market segments, enable our 

clients to see more, know more, and do more, which help to answer all their most important questions. 

In order to stay updated with technology and work process of the industry, MRFR often plans & 

conducts meet with the industry experts and industrial visits for its research analyst members. 

Contact: 

Market Research Future 

+1 646 845 9312 

Email: sales@marketresearchfuture.com 

News: Type 2 diabetes mellitus treatment market 2020 | Trends | Analysis - MRFR

 The Global Type 2 Diabetes Mellitus Market is expected to exhibit an upswing and capture a CAGR of 8% over the forecast period of 2017-2023, proclaims Market Research Future (MRFR) in an exhaustive research report. The global market is expanding at a rapid pace due to the increasing burden of type 2 diabetes across the globe. Type 2 diabetes mellitus has been increasing exponentially, and the market has observed a high prevalence rate in both developed and developing countries due to multiple risk factors of diabetes and delayed diagnosis. Development of novel efficient therapies is expected to create a supportive dais for building up the global type 2 diabetes mellitus market. The inefficiency of current therapies and life-threatening complications arising out of type 2 diabetes mellitus has necessitated the development of appropriate preventive measures.  

For Free Sample PDF Visit @https://www.marketresearchfuture.com/sample_request/5669

The government of various countries have initiated awareness programs and are investing heavily in research & development. Moreover, there has been a rise in the number of FDA approvals for new drugs which have also helped the market expand. Other driving factors include an increase in healthcare expenditure on a global scale and a rise in risk factors of type 2 diabetes mellitus. Conversely, the market growth might be hindered by lack of awareness, the high cost of treatment and diagnosis, complex regulatory framework for FDA approvals of therapies, and the side effects of available treatment options. 

Segmentation

The global type 2 diabetes mellitus treatment market has been segmented based on treatment and end user. By treatment, the market has been segmented into drug and devices. The drug segment has been further segmented into Insulin, Sensitizers, Sglt-2, Alpha-Glycosidase Inhibitors, Others. The devices segment has been further segmented into Blood Glucose Monitoring, Insulin Delivery Devices. By end user, the market has been segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others. 

Regional Analysis

The global type 2 diabetes mellitus treatment market spans across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas account for the largest share of the global type 2 diabetes mellitus market owing to the presence of a huge patient pool, well-developed healthcare sector, and the presence of leading players in the region. Moreover, due to the rising burden of diabetes mellitus on the healthcare, various companies and governments are endeavoring towards improving diabetes care. Europe is the second largest market for type 2 diabetes mellitus market. Government grants for research & Development coupled with favorable reimbursement scenario drive the market in Europe. Throughout Europe, charges for diagnosis and treatment of type 2 diabetes mellitus are covered under health insurance, especially for pregnant women. Asia Pacific is poised to be the fastest growing market on account of an epidemic increase in diabetes occurrence in the region which induces high demand for treatment and diagnosis. Also, the market is expanding due to substantial investment in the healthcare sector by the governments in the region. The Middle East & Africa market accounts for the least share of the market due to low healthcare penetration and poor medical facilities, especially in the Africa region. The Middle East market is expected to exhibit considerable growth over the forecast period due to improving the healthcare sector in the region. 

Competitive Landscape

The notable players operating in the global type 2 diabetes mellitus treatment market include Abbott Laboratories, Adocia, Amgen, Bayer AG, Dickinson and Company,  Boehringer Ingelheim, Eli Lilly,  Novo Nordisk, Pfizer, Sanofi,  Takeda Pharmaceuticals, Acon Laboratories, Inc., Akros Pharma, AstraZeneca, Becton, Biocon, Daiichi Sankyo, Merck, Novartis & Co., Peptron, Roche Diagnostics Ltd., Sunpharma, and others. 

Read More @ https://www.marketresearchfuture.com/reports/type-2-diabetes-mellitus-treatment-market-5669

About Market Research Future: 

Market Research Future 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various 

industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw 

Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting 

Services. 

MRFR team have supreme objective to provide the optimum quality market research and intelligence 

services to our clients. Our market research studies by products, services, technologies, applications, 

end users, and market players for global, regional, and country level market segments, enable our 

clients to see more, know more, and do more, which help to answer all their most important questions. 

In order to stay updated with technology and work process of the industry, MRFR often plans & 

conducts meet with the industry experts and industrial visits for its research analyst members. 

Contact: 

Market Research Future 

+1 646 845 9312 

Email: sales@marketresearchfuture.com 

Veterinary Pain Management Market -Size, share, 2020, Global Demand by 2027

Market Highlights: 

Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading 

awareness towards animal care. People are generally compassionate towards their pets, and they are 

increasingly becoming aware of animal physiology and psychology and the pain they go through during 

sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing 

number of pet owners and the strengthening bond between owners and their animal companions 

escalate the market on the global heights. 

Get Sample PDF @https://www.marketresearchfuture.com/sample_request/5961  

Acknowledging the rapid expansions, the market perceives currently, Market Research Future 

(MRFR) in its recently published study report asserts that the global Veterinary Pain Management Market is expected to register a CAGR of 6.46% during the assessment period of 2020 to 2027, to reach USD 4,582.8 Million by 2027.

Additional factors substantiating the market growth include the rising per capita income that is leading 

to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning 

animal cruelty is influencing people’s ideologies and knowledge about animals. 

Moreover, developments in animal health medicines and vaccines, along with the increased medical 

treatments are fostering the market growth of veterinary pain management market. Increased R&D 

expenditure to bring innovations in the products, and development of better and effective veterinary 

pharmaceuticals and vaccines, etc. are contributing to the market growth. 

Improving economic conditions worldwide foster market growth, enabling access to the quality of life, 

increasing consumers’ buying power, and availing cost-effective veterinary healthcare. 

On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well- 

being and the rising cost of pet care, etc. are expected to impede the market growth. Also, 

unavailability of skilled doctors is a major restraint the market is confronting with. Nevertheless, 

technological advancement, increasing number of ambulatory services coupled with the government 

and public organizations initiatives like PETA, working towards animal rights and liberation are 

expected to support market growth. 

 

Veterinary Pain Management Market - Segmentations 

Global Veterinary Pain Management Market, by Product

• Medication
  • NSAIDs
    • Meloxicam
    • Etodolac
    • Others
  • Opioids
    • Morphine
    • Codeine
    • Fentanyl
    • Hydromorphone
    • Others
  • Local Anesthetics
    • Lidocaine
    • Bupivacaine
    • Chloroprocaine
    • Others
  • Αlpha 2-Adrenergic Agonists
    • Medetomidine
    • Xylazine
    • Sedatives
    • Muscle Relaxants
    • Others
  • Route of Administration
    • Oral
    • Parenteral
    • Topical
• Devices
  • Laser Therapy Devices
  • Electromagnetic Therapy Devices

Global Veterinary Pain Management Market, by Animal Type

• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others
• Livestock Animals
  • Cattle
  • Pigs
  • Poultry
  • Others

Global Veterinary Pain Management Market, by Application

• Joint Pain
  • Osteoarthritis
  • Musculoskeletal Disorders
• Postoperative Pain
• Cancer
• Others

Global Veterinary Pain Management Market, by Distribution Channel

• Veterinary Hospitals & Clinics
• Pharmacies
• Online Pharmacies

Veterinary Pain Management Market - Geographical Analysis 

The North American region accounts for the leading market for veterinary pain management majorly 

due to the availability of a range of animal care products, emphasis on animal health, and stringent 

government regulations. Also, technological innovations in the field of veterinary surgical 

instruments are acting as a tailwind pushing up the market growth in the region. 

Additional factors such as growing insurance coverage schemes are expected to push the growth of 

the veterinary pain management market in the region. Moreover, the increasing number of pets and a 

large patients’ pool, contribute to the growth of the regional market, demanding various treatment 

procedures and surgeries. 

Countries such as Canada and the US are focusing on exporting surgical equipment and surgical 

suturing material across the world, which, in turn, is increasing the size of the market in this region. 

Besides, the growing number of veterinary hospitals fuel market growth. 

The Veterinary Pain Management Market in the European region stands the second position in terms 

of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the 

government. Increase in animal diseases has led to an increasing number of surgeries and veterinary 

healthcare organizations. European countries like Germany, France, and the U.K, backed by the 

 

significant expenditures in the field of manufacturing of veterinary medical and surgical devices, 

majorly contributes to the growth of the regional market. 

The Asia Pacific region is emerging as a promising market for companion veterinary pain 

management. China among other APAC dominates the regional market whereas, India accounts for 

the fastest growing market, followed by Australia and Japan. Factors such as the presence of a large 

patient’s pool, increasing awareness towards animal health, and the improving economy are few of 

the driving forces pushing up the market in the region. 

Veterinary Pain Management Market - Competitive Landscape 

The fiercely competitive veterinary pain management market appears to be fragmented due to many 

players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand 

reinforcement remain the popular trends for the market players. Acquisitions of local manufactures 

by multinational companies are changing the market structure, increasing the profit of the company 

by reducing the competition significantly. 

Key Players: 

Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé 

Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi 

Animal Health, Bayer, and Vetoquinol. 

Industry/ Innovation/ Related News: 

November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for 

large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. 

The rebranding includes new packaging for products and others. All EQUISTRO products are now 

available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine 

products. The rebranding strategy helps to expand the products available for performance horses 

through Vetoquinol. 

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961

About Market Research Future: 

Market Research Future 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various 

industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw 

Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting 

Services. 

MRFR team have supreme objective to provide the optimum quality market research and intelligence 

services to our clients. Our market research studies by products, services, technologies, applications, 

end users, and market players for global, regional, and country level market segments, enable our 

clients to see more, know more, and do more, which help to answer all their most important questions. 

In order to stay updated with technology and work process of the industry, MRFR often plans & 

conducts meet with the industry experts and industrial visits for its research analyst members. 

Contact: 

Market Research Future 

+1 646 845 9312 

Email: sales@marketresearchfuture.com